Literature DB >> 3621474

Phenobarbital induction of cytochrome P-450 in normal and preneoplastic rat liver: comparison of enzyme and mRNA expression as detected by immunohistochemistry and in situ hybridization.

M Schwarz, G Peres, A Buchmann, T Friedberg, D J Waxman, W Kunz.   

Abstract

The expression levels of the major phenobarbital-inducible cytochromes P-450 were analyzed immunohistochemically in liver sections obtained from rats treated sequentially with diethylnitrosamine and phenobarbital. In parallel sections expression of the corresponding messenger RNAs was investigated by in situ hybridization using an appropriate 35S-labeled cDNA probe. A phenobarbital-mediated increase in enzyme protein and a concomitant enhancement of the corresponding mRNA was seen in hepatocytes of the centrilobular areas of the liver acinus. A comparable increase in P-450 protein and mRNA expression was detected in large carcinogen-induced nodules present in animals maintained on phenobarbital until killing. This result was confirmed by Northern analysis of nodular RNA. No such induction was seen in liver nodules obtained from animals which were withdrawn from the phenobarbital-containing diet 10 days prior to killing. These findings demonstrate that phenobarbital induction of cytochrome P-450 enzymes occurs in neoplastic liver tissue as it does in normal liver and, in addition, suggest that the increase in the levels of the major phenobarbital-inducible P-450s in normal and neoplastic liver is mediated by an enhancement of the steady-state concentrations of their mRNAs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621474     DOI: 10.1093/carcin/8.9.1355

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

1.  Variations in immunoreactivity for phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450, and NADPH-cytochrome P-450 reductase in rat liver over twenty-four hours.

Authors:  S Waguri; T Iyanagi; Y Uchiyama
Journal:  Histochemistry       Date:  1992

Review 2.  Zonation of hepatic cytochrome P-450 expression and regulation.

Authors:  T Oinonen; K O Lindros
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

3.  Predominant periportal expression of the fructose 1,6-bisphosphatase gene in rat liver: dynamics during the daily feeding rhythm and starvation-refeeding cycle.

Authors:  F Eilers; S Modaressi; K Jungermann
Journal:  Histochem Cell Biol       Date:  1995-04       Impact factor: 4.304

4.  Assessment of the labelling index of cohorts of the pancreatic islet cell population in phenobarbitone-treated male rats using a double immunohistochemical technique for 5-bromo-2'-deoxyuridine and pancreatic hormones.

Authors:  H B Jones; S J Harbottle; A L Bowdler
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

5.  Zonal expression of the glucokinase gene in rat liver. Dynamics during the daily feeding rhythm and starvation-refeeding cycle demonstrated by in situ hybridization.

Authors:  F Eilers; H Bartels; K Jungermann
Journal:  Histochemistry       Date:  1993-02

6.  Assessment of the influence of subacute phenobarbitone administration on multi-tissue cell proliferation in the rat using bromodeoxyuridine immunocytochemistry.

Authors:  H B Jones; N A Clarke
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

7.  Predominant periportal expression of the phosphoenolpyruvate carboxykinase and tyrosine aminotransferase genes in rat liver. Dynamics during the daily feeding rhythm and starvation-refeeding cycle demonstrated by in situ hybridization.

Authors:  H Bartels; H Herbort; K Jungermann
Journal:  Histochemistry       Date:  1990

8.  Phenobarbital induces alterations in the proteome of hepatocytes and mesenchymal cells of rat livers.

Authors:  Philip Klepeisz; Sandra Sagmeister; Verena Haudek-Prinz; Melanie Pichlbauer; Bettina Grasl-Kraupp; Christopher Gerner
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

9.  Association between responsiveness to phenobarbital induction of CYP2B1/2 and 3A1 in rat hepatic hyperplastic nodules and their zonal origin.

Authors:  Z Y Chen; D L Eaton
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

10.  Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of hepatocarcinogenesis: immunohistochemical analysis of cytochrome P-450 isozyme induction by 2-acetylaminofluorene and phenobarbital.

Authors:  M Asamoto; H Tsuda; T Kato; N Ito; T Masuko; Y Hashimoto; S Nagase
Journal:  Jpn J Cancer Res       Date:  1989-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.